You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,429,602


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,429,602
Title:Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva
Abstract:Treating allergic conjunctivitis by administered aqueous solutions containing epinastine, optionally in the form of its racemate or its enantiomers and optionally, in the form of the pharmacologically acceptable acid addition salts thereof, to the conjunctiva.
Inventor(s): Trach; Volker (Biberach, DE), Duschler; Gerold (Ehingen, DE)
Assignee: Boehringer Ingelheim Pharma GmbH & Co. Kg (Ingelheim, DE)
Application Number:11/863,008
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,429,602: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the specifics of United States Patent 7,429,602, exploring its claims, scope, and the broader patent landscape.

Understanding Patent Scope

Patent scope is a critical aspect of patent analysis, often debated in the context of patent quality. It refers to the breadth and clarity of the claims made in a patent. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Claims Analysis

Independent Claim Length and Count

Two key metrics for measuring patent scope are independent claim length (ICL) and the total number of independent claims (ICC). These metrics help in assessing the complexity and breadth of the patent claims. For example, a patent with shorter independent claims and fewer independent claims generally indicates a narrower scope, which can be more easily enforced and less likely to face litigation challenges[3].

Claim Construction

The construction of claims is a vital step in patent examination. Judges and examiners must interpret the language of the claims to determine the patent's scope. Changes in claim construction during the examination process can significantly narrow the scope of the patent, making it more specific and less prone to disputes[3].

United States Patent 7,429,602: Overview

To analyze the specific patent, we need to look at its claims, description, and any relevant prior art.

Patent Title and Abstract

The title and abstract provide a preliminary understanding of the invention. For instance, if the patent is titled "Method and System for [Specific Technology]," the abstract would briefly describe the method and system, highlighting its novelty and nonobviousness.

Claims

The claims section is the most critical part of the patent, as it defines the scope of the invention. Here, you would look at the independent and dependent claims to understand what is being protected. Independent claims stand alone and define the invention, while dependent claims refer back to the independent claims and add additional limitations.

Description and Drawings

The detailed description and drawings provide context to the claims, explaining how the invention works and its various embodiments. This section helps in understanding the technical aspects of the invention and how it differs from prior art.

Searching and Analyzing Prior Art

Using USPTO Resources

To analyze the scope and claims of a patent, it is essential to conduct a thorough prior art search. The USPTO provides several tools for this purpose, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. This tool offers enhanced access to prior art and modern interfaces for a more efficient search process[1].

Global Dossier and Common Citation Document

The Global Dossier service allows users to access the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related citations. The Common Citation Document (CCD) consolidates citation data from multiple offices, helping to visualize the prior art cited by different offices for the same invention[1].

International Patent Landscape

Searching International Patent Offices

To ensure the invention is novel and nonobvious globally, it is crucial to search international patent databases. Resources like the European Patent Office's esp@cenet, the Japan Patent Office's database, and WIPO's PATENTSCOPE provide access to international patent applications and granted patents. These databases often include machine translations to facilitate searches in different languages[1].

Patent Assignment and Ownership

Patent Assignment Search

Understanding the ownership and assignment history of a patent can be vital for licensing, litigation, and other business decisions. The USPTO's Patent Assignment Search website allows users to search for patent assignments and changes in ownership[1].

Patent Examination Data

Patent Examination Data System (PEDS)

The PEDS system provides public access to bibliographic data for all publicly available patent applications. This data can help in analyzing the examination process, including the duration and outcomes of patent examinations, which can provide insights into the patent's scope and validity[1].

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are crucial metrics for assessing patent scope.
  • Claim Construction: Changes in claim construction during the examination process can significantly impact the patent's scope.
  • Prior Art Search: Thorough prior art searches using USPTO and international resources are essential for validating the novelty and nonobviousness of an invention.
  • International Landscape: Searching international patent databases ensures the invention's global novelty and nonobviousness.
  • Ownership and Assignment: Understanding patent ownership and assignment history is vital for business decisions.

FAQs

What is the importance of independent claim length and count in patent scope analysis?

Independent claim length and count are key metrics that help in assessing the complexity and breadth of patent claims. Narrower claims with fewer words and fewer independent claims generally indicate a more specific and enforceable patent.

How can I conduct a thorough prior art search for a patent?

You can use the USPTO's Patent Public Search tool, Global Dossier, and Common Citation Document, as well as international patent databases like esp@cenet and PATENTSCOPE, to conduct a comprehensive prior art search.

What is the role of the Patent Examination Data System (PEDS) in patent analysis?

PEDS provides public access to bibliographic data for all publicly available patent applications, allowing users to analyze the examination process, including duration and outcomes, which can provide insights into the patent's scope and validity.

How do changes in claim construction affect the patent's scope?

Changes in claim construction during the examination process can significantly narrow the scope of the patent, making it more specific and less prone to disputes and litigation challenges.

Why is it important to search international patent databases?

Searching international patent databases ensures that the invention is novel and nonobvious globally, which is crucial for maintaining the validity of the patent and avoiding potential infringement issues.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims and Patent Scope - Hoover Institution: https://www.hoover.org/sites/default/files/ip2-wp16001-paper.pdf
  4. Invention: U.S. and Comparative Global Trends: https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends
  5. Report on Filing Patent/Trademark | United States Courts: https://www.uscourts.gov/forms-rules/forms/report-filing-patent-trademark

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,429,602

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,429,602

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 54 516Nov 12, 1999

International Family Members for US Patent 7,429,602

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 026424 ⤷  Subscribe
Austria 353218 ⤷  Subscribe
Australia 1138101 ⤷  Subscribe
Australia 2006201541 ⤷  Subscribe
Australia 784017 ⤷  Subscribe
Bulgaria 106681 ⤷  Subscribe
Bulgaria 65775 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.